Tags

Type your tag names separated by a space and hit enter

[Intravitreal bevacizumab followed by focal laser for diffuse diabetic macular edema of recent progression. A clinical case].
Arch Soc Esp Oftalmol 2009; 84(4):209-12AS

Abstract

CASE REPORT

We report the case of a 48-year-old man with diffuse diabetic macular edema of recent progression treated with two consecutive intravitreal injections of bevacizumab followed by focal laser therapy, with good anatomic and functional response.

DISCUSSION

Diffuse diabetic macular edema is difficult to manage and frequently requires multiple therapies. We propose the use of bevacizumab as a strategy to reduce diffuse macular edema, facilitating the application of laser therapy.

Authors+Show Affiliations

Servicio de Oftalmología, Hospital Ramón y Cajal, Madrid, España. mqmorenol@yahoo.esNo affiliation info available

Pub Type(s)

Case Reports
English Abstract
Journal Article

Language

spa

PubMed ID

19384761

Citation

Moreno-López, M, and A Regueras. "[Intravitreal Bevacizumab Followed By Focal Laser for Diffuse Diabetic Macular Edema of Recent Progression. a Clinical Case]." Archivos De La Sociedad Espanola De Oftalmologia, vol. 84, no. 4, 2009, pp. 209-12.
Moreno-López M, Regueras A. [Intravitreal bevacizumab followed by focal laser for diffuse diabetic macular edema of recent progression. A clinical case]. Arch Soc Esp Oftalmol. 2009;84(4):209-12.
Moreno-López, M., & Regueras, A. (2009). [Intravitreal bevacizumab followed by focal laser for diffuse diabetic macular edema of recent progression. A clinical case]. Archivos De La Sociedad Espanola De Oftalmologia, 84(4), pp. 209-12.
Moreno-López M, Regueras A. [Intravitreal Bevacizumab Followed By Focal Laser for Diffuse Diabetic Macular Edema of Recent Progression. a Clinical Case]. Arch Soc Esp Oftalmol. 2009;84(4):209-12. PubMed PMID: 19384761.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Intravitreal bevacizumab followed by focal laser for diffuse diabetic macular edema of recent progression. A clinical case]. AU - Moreno-López,M, AU - Regueras,A, PY - 2009/4/23/entrez PY - 2009/4/23/pubmed PY - 2009/8/25/medline SP - 209 EP - 12 JF - Archivos de la Sociedad Espanola de Oftalmologia JO - Arch Soc Esp Oftalmol VL - 84 IS - 4 N2 - CASE REPORT: We report the case of a 48-year-old man with diffuse diabetic macular edema of recent progression treated with two consecutive intravitreal injections of bevacizumab followed by focal laser therapy, with good anatomic and functional response. DISCUSSION: Diffuse diabetic macular edema is difficult to manage and frequently requires multiple therapies. We propose the use of bevacizumab as a strategy to reduce diffuse macular edema, facilitating the application of laser therapy. SN - 0365-6691 UR - https://www.unboundmedicine.com/medline/citation/19384761/[Intravitreal_bevacizumab_followed_by_focal_laser_for_diffuse_diabetic_macular_edema_of_recent_progression__A_clinical_case]_ L2 - http://www.oftalmo.com/seo/archivos/pubmed_links/pubmed_index.php?id=2477 DB - PRIME DP - Unbound Medicine ER -